GlassScriptPhysician profile
Esther Kim
NPI 1891938817
$1,926.49
in general payments reported to CMS, 2019-2025
14 companies · $81.41 in 2025
The $81.41 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $900 · 2020: $57.73 · 2021: $322 · 2022: $68.75 · 2023: $298 · 2024: $198 · 2025: $81.41.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $578.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $578.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $493.61 | 2019-2021 | |
| Spineology INC. | $391.98 | 2019-2022 | |
| Medtronic, INC. | $343.87 | 2021-2023 | Osteocool Rf Ablation System, Mazor X System, Kyphon Express II Kyphopak Tray |
| Si-Bone, INC. | $236.82 | 2023-2024 | |
| Depuy Synthes Sales INC. | $150.13 | 2019-2023 | Skyline |
| Integra Lifesciences Corporation | $84.02 | 2019-2025 | Duraseal Exact Spinal Sealant System, Cusa Clarity, Codman Certas |
| Aesculap, INC. | $42.50 | 2024 | Paedigav |
| Genentech USA, INC. | $38.32 | 2023 | Vabysmo |
| Lazarus 3d | $33.94 | 2024 | Pre-Sure |
| Left Coast Surgical INC | $32.76 | 2025 | |
| Medical Device Business Services, INC. | $23.75 | 2022 | |
| Cerapedics INC. | $22.50 | 2025 | I-Factor Peptide Enhanced Bone Graft |
| Abbvie INC. | $17.79 | 2024 | |
| Surgalign Spine Technologies, INC. | $14.50 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Esther Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.